General Motors Unveils AllElectric Cadillac Vistiq with 300Mile Range Oura Health Files Confidentially for IPO Signaling Growth in Wearable Tech Market RBC Capital Resumes Coverage on Danaher Corporation DHR What Investors Should Know ADP Private Payrolls Rise 109000 in April Topping Expectations Signaling Steady Labor Market Germany Pursues Closer China Trade Ties Despite EU Pressure for Tougher Stance Plus500 Reports 11 Quarterly Revenue Growth Reaffirms FullYear Outlook LNKB Q4 2025 Earnings EPS Misses Estimates by Wide Margin Stock Unchanged Bank of America Q1 2026 Earnings EPS Surges Past Expectations as Net Interest Income Holds Steady Tenax Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Amid Continued Clinical Development Paycom Q1 2026 Earnings EPS Tops Estimates Stock Slips Despite Strong Performance AVIR Q1 2026 Earnings NarrowerThanExpected Loss Boosts Investor Sentiment CWAN Q1 2026 Earnings Slight EPS Miss Amid Steady Performance ASGN Inc Plunges 5169 Key Levels and Technical Outlook for the Staffing Specialist RXO Inc RXO Holds Steady Near Resistance as Trading Volume Signals Caution Aviat Networks Surges 693 as Stock Bounces Off Key Support Axiom Intelligence Acquisition Corp 1 Holds Steady at 1036 SPAC Trading in a Tight Range ICU Medical ICUI Advances 177 Approaching Key Resistance at 14783 Amazons Fashion Influence Deepens Met Gala Ties Spark Industry Debate Blackstone Mortgage Trust Inc BXMT Q1 2026 Earnings EPS Misses Estimates as Credit Conditions Challenge Originations Allied Gold Holds Steady Near Resistance as Consolidation Continues FMC Q1 2026 Earnings NarrowerThanExpected Loss Boosts Investor Sentiment Value Line Inc VALU Q1 2026 Earnings EPS of 069 Reported Amid Limited Analyst Coverage LXP Q1 2026 Earnings Industrial REIT Posts Wider Loss Than Expected Shares Edge Higher Guardant Health Q1 2026 Earnings NarrowerThanExpected Loss Lifts Shares Ingredion Q1 2026 Earnings EPS Misses Estimates Amid Challenging Operating Environment Xenetic Biosciences Q2 2025 Earnings Narrowed Loss Exceeds Expectations Amid Oncology Pipeline Progress COMPASS Pathways Plc Q1 2026 Earnings Narrower Loss Provides Hope Amid PreRevenue Stage